{"id":"https://openalex.org/W4391303393","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.171","title":"Comparative survival in metastatic castration-sensitive prostate cancer (mCSPC) by prognostic subgroups: A living network meta-analysis.","display_name":"Comparative survival in metastatic castration-sensitive prostate cancer (mCSPC) by prognostic subgroups: A living network meta-analysis.","publication_year":2024,"publication_date":"2024-01-29","ids":{"openalex":"https://openalex.org/W4391303393","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.171"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.4_suppl.171","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.171","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.4_suppl.171","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067550666","display_name":"Syed Arsalan Ahmed Naqvi","orcid":"https://orcid.org/0000-0002-3131-2088","observed_orcids":["https://orcid.org/0000-0002-3131-2088"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syed Arsalan Ahmed Naqvi","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018306647","display_name":"Irbaz Bin Riaz","orcid":"https://orcid.org/0000-0003-4249-0311","observed_orcids":["https://orcid.org/0000-0003-4249-0311"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irbaz Bin Riaz","raw_affiliation_strings":["Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047661479","display_name":"Kaneez Zahra Rubab Khakwani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaneez Zahra Rubab Khakwani","raw_affiliation_strings":["University of Arizona, Tucson, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona, Tucson, AZ","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101209245","display_name":"Arifa Bibi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arifa Bibi","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004426786","display_name":"Jack R. Andrews","orcid":"https://orcid.org/0000-0002-7781-3638","observed_orcids":["https://orcid.org/0000-0002-7781-3638"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack R. Andrews","raw_affiliation_strings":["Mayo Clinic Arizona, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Phoenix, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016092330","display_name":"Daniel S. Childs","orcid":"https://orcid.org/0000-0001-7643-2836","observed_orcids":["https://orcid.org/0000-0001-7643-2836"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel S Childs","raw_affiliation_strings":["Department of Medical Oncology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036761306","display_name":"Praful Kumar Ravi","orcid":"https://orcid.org/0000-0002-7466-4702","observed_orcids":["https://orcid.org/0000-0002-7466-4702"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Praful Ravi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005887623","display_name":"Jacob J. Orme","orcid":"https://orcid.org/0000-0002-0319-0239","observed_orcids":["https://orcid.org/0000-0002-0319-0239"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob Orme","raw_affiliation_strings":["Department of Medical Oncology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074582149","display_name":"Parminder Pal Singh","orcid":"https://orcid.org/0000-0002-2851-6805","observed_orcids":["https://orcid.org/0000-0002-2851-6805"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Parminder Singh","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002909668","display_name":"Christopher J. Sweeney","orcid":"https://orcid.org/0000-0002-0398-6018","observed_orcids":["https://orcid.org/0000-0002-0398-6018"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christopher Sweeney","raw_affiliation_strings":["South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030233600","display_name":"Alan Haruo Bryce","orcid":"https://orcid.org/0000-0002-0206-3895","observed_orcids":["https://orcid.org/0000-0002-0206-3895"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Haruo Bryce","raw_affiliation_strings":["Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"4_suppl","first_page":"171","last_page":"171"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-hormone-sensitive-prostate-cancer","display_name":"metastatic hormone-sensitive prostate cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7429999709129333},{"id":"https://openalex.org/keywords/prognostic-subgroups","display_name":"prognostic subgroups","score":0.9089999794960022},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/darolutamide","display_name":"darolutamide","score":0.8190000057220459},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9629999995231628},{"id":"https://openalex.org/keywords/apalutamide","display_name":"apalutamide","score":0.9959999918937683},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9800000190734863},{"id":"https://openalex.org/keywords/systemic-treatment","display_name":"systemic therapy","score":0.6330000162124634},{"id":"https://openalex.org/keywords/treatment-ranking","display_name":"treatment ranking","score":0.421999990940094},{"id":"https://openalex.org/keywords/p-score","display_name":"P-score","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8966725468635559},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7654949426651001},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6889938712120056},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6323316097259521},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6036149263381958},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.4602372646331787},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4587670862674713},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4060748815536499},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.37721216678619385}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.4_suppl.171","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.171","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.4_suppl.171","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415870862","https://openalex.org/W4324137080","https://openalex.org/W6925369782","https://openalex.org/W3031711911","https://openalex.org/W4322757808","https://openalex.org/W3159923585","https://openalex.org/W4221038749","https://openalex.org/W3119125273","https://openalex.org/W4213256481","https://openalex.org/W4399394681"],"abstract_inverted_index":{"171":[0],"Background:":[1],"Treatment":[2],"effects":[3],"vary":[4],"by":[5,36,74],"volume":[6,85,89,93,98],"of":[7,11,24,31,137],"disease":[8],"and":[9,69,95,169,188,259,283,302,336,345,351],"timing":[10],"metastatic":[12],"presentation":[13],"in":[14,34,67,110,121,331,340,349,357],"patients":[15,146,178,218,267],"with":[16,123,140,147,179,233,268],"mCSPC.":[17,359],"Therefore,":[18],"we":[19],"updated":[20],"the":[21,28,52,211],"existing":[22],"body":[23],"evidence":[25,55,322],"to":[26,39,116,157,200,208,240,276,295],"assess":[27,117],"comparative":[29],"efficacy":[30],"systemic":[32,65,326,334,343],"therapy":[33,66,327],"mCSPC":[35,68],"prognostic":[37,76],"subgroups":[38,77,81],"inform":[40],"clinical":[41,61],"practice":[42],"guidelines.":[43],"Methods:":[44],"This":[45,132],"living":[46,53],"systematic":[47],"review":[48],"was":[49],"conducted":[50],"using":[51,106],"interactive":[54],"(LIvE)":[56],"synthesis":[57],"framework.":[58],"Phase":[59],"III":[60],"trials":[62,139],"assessing":[63],"contemporary":[64],"reporting":[70],"overall":[71],"survival":[72],"(OS)":[73],"four":[75],"were":[78,104,114,213,225,314],"included.":[79],"Prognostic":[80],"included":[82,134],"synchronous":[83,87],"high":[84,92],"(SHV),":[86],"low":[88,97],"(SLV),":[90],"metachronous":[91,96],"(MHV),":[94],"(MLV)":[99],"disease.":[100],"Mixed":[101],"treatment":[102,119,143,229,318],"comparisons":[103],"made":[105],"a":[107,135],"network-meta-analytic":[108],"approach":[109],"each":[111],"subgroup.":[112],"P-scores":[113],"used":[115],"relative":[118],"rankings":[120],"congruency":[122],"pairwise":[124],"estimates.":[125],"Higher":[126],"scores":[127],"indicated":[128],"better":[129],"efficacy.":[130],"Results:":[131],"study":[133],"total":[136],"nine":[138],"eight":[141],"unique":[142],"options.":[144],"In":[145,177,217,266],"SHV":[148],"disease,":[149,181,220,270],"darolutamide+docetaxel+ADT":[150],"(DARO+D+ADT)":[151],"significantly":[152,195,272],"improved":[153,196,273,292],"OS":[154,197,232,274,293],"when":[155,198,238],"compared":[156,199,207,239,275,294],"D+ADT":[158,241,284,303],"(HR:":[159,164,172,183,190,242,248,254,261,278,285,297,304],"0.69;":[160,243],"0.57-0.85),":[161],"enzalutamide":[162],"(E)+ADT":[163],"0.67;":[165,255],"95%":[166,174,185,192,244,250,256,263,280,287,299,306],"CI:":[167,175,186,193,245,251,257,264,281,288,300,307],"0.46-0.99),":[168],"apalutamide":[170],"(APA)+ADT":[171],"0.65;":[173],"0.43-0.96).":[176],"SLV":[180],"E+ADT":[182,253,271],"0.62;":[184],"0.42-0.91)":[187],"AAP+ADT":[189],"0.66;":[191],"0.49-0.89)":[194],"ADT.":[201],"Although":[202],"E+D+ADT":[203,260],"trended":[204,235],"toward":[205,236],"improvement":[206,237],"other":[209,310],"treatments,":[210],"results":[212],"not":[214],"statistically":[215,222,311],"significant.":[216],"withMHV":[219],"no":[221],"significant":[223,291,312],"differences":[224,313],"observed":[226,315],"among":[227,316],"mixed":[228,317],"comparisons.":[230,319],"However,":[231],"DARO+D+ADT":[234],"0.39-1.23),":[246],"APA+ADT":[247,290],"0.72;":[249],"0.23-2.33),":[252],"0.24-1.86),":[258],"0.59;":[262],"0.26-1.34).":[265],"MLV":[269,358],"ADT":[277,296],"0.51;":[279],"0.32-0.79),":[282],"0.48;":[286],"0.27-0.85).":[289],"0.22;":[298],"0.09-0.54),":[301],"0.21;":[305],"0.08-0.55).":[308],"No":[309],"Conclusions:":[320],"Current":[321],"suggests":[323],"that":[324],"triplet":[325,335,344],"may":[328],"be":[329],"preferred":[330],"SHV,":[332],"E":[333,337,354],"hormonal":[338,347,355],"doublet":[339,348],"SLV,":[341],"DARO":[342],"APA":[346,352],"MHV,":[350],"or":[353],"doublets":[356],"[Table:":[360],"see":[361],"text]":[362]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-01-30T00:00:00"}